Emcure Pharmaceuticals Ltd:企業の戦略的SWOT分析

◆英語タイトル:Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review
◆商品コード:DATA904C12939
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Emcure Pharmaceuticals Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Emcure Pharmaceuticals Ltd (Emcure) develops, manufactures and markets a range of pharmaceutical products worldwide. The company develops and manufactures branded generic products. It also manufactures active pharmaceutical ingredients (APIs) primarily for use in manufacturing of pharmaceutical products. Emcure has presence in all major therapeutic areas including cardiology, pain and analgesics, HIV, gynecology, blood related, anti-infective, nephrology, diabetes and cancer among others as well as vitamins, minerals and nutrients products. It operates in Brazil, Dubai, South Africa, Singapore and Nigeria. The company has branch offices in Russia and Morocco. Emcure is headquartered in Pune, Maharashtra, India.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Emcure Pharmaceuticals Ltd – Key Facts 5
Emcure Pharmaceuticals Ltd – Key Employees 6
Emcure Pharmaceuticals Ltd – Key Employee Biographies 7
Emcure Pharmaceuticals Ltd – Major Products and Services 8
Emcure Pharmaceuticals Ltd – History 9
Emcure Pharmaceuticals Ltd – Company Statement 11
Emcure Pharmaceuticals Ltd – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 14
Company Overview 14
Emcure Pharmaceuticals Ltd – Business Description 15
Emcure Pharmaceuticals Ltd – Corporate Strategy 16
Emcure Pharmaceuticals Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
Emcure Pharmaceuticals Ltd – Strengths 17
Emcure Pharmaceuticals Ltd – Weaknesses 18
Emcure Pharmaceuticals Ltd – Opportunities 19
Emcure Pharmaceuticals Ltd – Threats 20
Emcure Pharmaceuticals Ltd – Key Competitors 21
Section 3 – Company’s Lifesciences Financial Deals and Alliances 22
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23
Emcure Pharmaceuticals Ltd, Recent Deals Summary 24
Section 4 – Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Emcure Pharmaceuticals Ltd, Key Facts 5
Emcure Pharmaceuticals Ltd, Key Employees 6
Emcure Pharmaceuticals Ltd, Key Employee Biographies 7
Emcure Pharmaceuticals Ltd, Major Products and Services 8
Emcure Pharmaceuticals Ltd, History 9
Emcure Pharmaceuticals Ltd, Subsidiaries 12
Emcure Pharmaceuticals Ltd, Key Competitors 21
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23
Emcure Pharmaceuticals Ltd, Recent Deals Summary 24

List of Figures
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 23

★海外企業調査レポート[Emcure Pharmaceuticals Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CGU Insurance Ltd:企業の戦略・SWOT・財務分析
    CGU Insurance Ltd - Strategy, SWOT and Corporate Finance Report Summary CGU Insurance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Elementis plc (ELM):企業の財務・戦略的SWOT分析
    Elementis plc (ELM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Acxiom Corporation:企業の戦略・SWOT・財務分析
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aviragen Therapeutics Inc (AVIR)-製薬・医療分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Dermira Inc (DERM)-医療機器分野:企業M&A・提携分析
    Summary Dermira Inc (Dermira) is a bio-pharmaceutical company which concentrates on the development and commercialization of novel therapies for the treatment of chronic skin conditions. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atop …
  • Risk Strategies Company Inc:企業のM&A・事業提携・投資動向
    Risk Strategies Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Risk Strategies Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Taiwan High Speed Rail Corporation
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Maruishi Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Maruishi Pharmaceutical Co Ltd (Maruishi) is a pharmaceutical company that develops and sells medical drugs. The company offers products in the fields of perioperative and infection control. Its products include anesthetics, perioperative drugs, pharmacopoeia drugs, and disinfectants and ant …
  • Galena Biopharma Inc (GALE)-医療機器分野:企業M&A・提携分析
    Summary Galena Biopharma Inc (Galena) is a biopharmaceutical company that develops and markets therapies for the treatment of unmet medical needs and advance care. The company's pipeline products comprise NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 and GALE-301 folate binding pro …
  • OAO Tatneft:企業の戦略・SWOT・財務情報
    OAO Tatneft - Strategy, SWOT and Corporate Finance Report Summary OAO Tatneft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Universal Travel Group:企業の戦略・SWOT・財務分析
    Universal Travel Group - Strategy, SWOT and Corporate Finance Report Summary Universal Travel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Allscripts Healthcare Solutions, Inc.:企業の戦略・SWOT・財務情報
    Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Albireo Pharma Inc (ALBO):医療機器:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Biofrontera AG (B8F):医療機器:M&Aディール及び事業提携情報
    Summary Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic kerat …
  • U.S. HealthWorks Medical Group:製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. HealthWorks Medical Group (U.S. HealthWorks), a subsidiary of Dignity Health, is a healthcare service provider that offers medicine and urgent care services. The center’s services include occupational medicine, urgent care, specialty care and therapy services. Its occupational medicine …
  • Yamato Holdings Co Ltd (9064):企業の財務・戦略的SWOT分析
    Yamato Holdings Co Ltd (9064) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Breckenridge Pharmaceutical Inc:企業のM&A・事業提携・投資動向
    Breckenridge Pharmaceutical Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Breckenridge Pharmaceutical Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Syneron Medical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Syneron Medical Ltd (Syneron Candela), subsidiary of Apax Partners LLP, is a non-surgical aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of non-invasive aesthetic medical procedures and address wide range of …
  • Inform Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆